SNF.Back to Emerging
Emerging Detail

BLSM - BlossomHill Therapeutics, Inc.

Candidate

SNF Emerging Watchlist(TM) tracks newly public companies positioned around emerging economic themes. Inclusion reflects SNF research interest and ongoing monitoring; it is not a recommendation to buy, sell, or hold a security.

Emerging Score
83 / 100
Confidence
93%
Band
Strong Emerging Profile
Last Reviewed
Oct 23, 2026
Primary Theme
Biotechnology / Health Innovation
Exchange
Nasdaq
Current Thesis

Growth / Traction

What Changed

Candidate to Candidate review completed.

Why It Matters

Growth / Traction

What The Market Is Pricing In

Market Confirmation currently scores 50/100 within the Emerging Score framework.

What Could Change The Narrative

Early-stage oncology execution and durability of response data

SNF Lens
Signal
Growth / Traction
Noise
Some evidence needs refresh context.
Confirmation
Market Confirmation 50/100
Risk
Early-stage oncology execution and durability of response data
Six-Family Scorecard
Structural Theme Relevance
88
Business Quality
84
Growth / Traction
91
Competitive Position
88
Financial Durability
84
Market Confirmation
50
Key Risks
Early-stage oncology execution and durability of response data
Clinical safety, competitive intensity and cash burn
Evidence Quality
Active Evidence
6
Sources
5
Stale Evidence
1
Freshness
Mixed freshness
Review / Score History
Oct 23, 2026Thesis unchanged - Candidate unchanged
Oct 23, 2026Score 83 / Confidence 93 / Candidate
Oct 4, 2026Score 83 / Confidence 93 / Candidate
Sources
ir.bhtherapeutics.com
company-ir - Sep 18, 2026
Open source
ir.bhtherapeutics.com
company-ir - Sep 15, 2026
Open source
sec.gov
sec-filing - Sep 15, 2026
Open source
stockanalysis.com
market-data - Oct 4, 2026
Open source
ir.bhtherapeutics.com
company-ir - Oct 4, 2026
Open source